Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulating Th2 cell levels via vMIP-I/CCR8 interaction

Modulating Th2 cell levels via vMIP-I/CCR8 interaction

US Patent 6416954 · Granted Jul 9, 2002

Estimated economic value: $63,501,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating pre-type 1 diabetes in a human subject2021
Anti-TNF antibodies, compositions, methods and use for the treatment or preventi2019
Method of reducing total cholesterol level by administering matrilin-2 polypepti2015
Anti-PCSK9 and methods for treating lipid and cholesterol disorders2013
Nucleic acids encoding CCL272012
Anti-CCL27 antibodies2009
Histamine receptor2009
Adenosine receptor2008
DNAXCCR102007
Mammalian cytokines; related reagents and methods2007
Histamine receptor antibody2007
Adenosine receptor2007